27 related articles for article (PubMed ID: 15381113)
1. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.
Lee FFY; Alper S
Front Immunol; 2022; 13():1023567. PubMed ID: 36531997
[TBL] [Abstract][Full Text] [Related]
2. sTLR4/sMD-2 complex alleviates LPS-induced acute lung injury by inhibiting pro-inflammatory cytokines and chemokine CXCL1 expression.
Meng J; Zou Y; Chen J; Qin F; Chen X; Chen X; Dai S
Exp Ther Med; 2018 Dec; 16(6):4632-4638. PubMed ID: 30542414
[TBL] [Abstract][Full Text] [Related]
3. Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.
Blumhagen RZ; Hedin BR; Malcolm KC; Burnham EL; Moss M; Abraham E; Huie TJ; Nick JA; Fingerlin TE; Alper S
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L930-L939. PubMed ID: 28775099
[TBL] [Abstract][Full Text] [Related]
4. Widespread Shortening of 3' Untranslated Regions and Increased Exon Inclusion Are Evolutionarily Conserved Features of Innate Immune Responses to Infection.
Pai AA; Baharian G; Pagé Sabourin A; Brinkworth JF; Nédélec Y; Foley JW; Grenier JC; Siddle KJ; Dumaine A; Yotova V; Johnson ZP; Lanford RE; Burge CB; Barreiro LB
PLoS Genet; 2016 Sep; 12(9):e1006338. PubMed ID: 27690314
[TBL] [Abstract][Full Text] [Related]
5. miR-155 targets Caspase-3 mRNA in activated macrophages.
De Santis R; Liepelt A; Mossanen JC; Dueck A; Simons N; Mohs A; Trautwein C; Meister G; Marx G; Ostareck-Lederer A; Ostareck DH
RNA Biol; 2016; 13(1):43-58. PubMed ID: 26574931
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
[TBL] [Abstract][Full Text] [Related]
7. Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex.
O'Connor BP; Danhorn T; De Arras L; Flatley BR; Marcus RA; Farias-Hesson E; Leach SM; Alper S
PLoS Genet; 2015 Feb; 11(2):e1004932. PubMed ID: 25658809
[TBL] [Abstract][Full Text] [Related]
8. Alternatively spliced myeloid differentiation protein-2 inhibits TLR4-mediated lung inflammation.
Tumurkhuu G; Dagvadorj J; Jones HD; Chen S; Shimada K; Crother TR; Arditi M
J Immunol; 2015 Feb; 194(4):1686-94. PubMed ID: 25576596
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of gene expression in innate immunity.
Carpenter S; Ricci EP; Mercier BC; Moore MJ; Fitzgerald KA
Nat Rev Immunol; 2014 Jun; 14(6):361-76. PubMed ID: 24854588
[TBL] [Abstract][Full Text] [Related]
10. Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.
De Arras L; Alper S
PLoS Genet; 2013 Oct; 9(10):e1003855. PubMed ID: 24204290
[TBL] [Abstract][Full Text] [Related]
11. Significance of MD-2 and MD-2B expression in rat liver during acute cholangitis.
Miao HL; Qiu ZD; Hao FL; Bi YH; Li MY; Chen M; Chen NP; Zhou F
World J Hepatol; 2010 Jun; 2(6):233-8. PubMed ID: 21161002
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.
Gray P; Michelsen KS; Sirois CM; Lowe E; Shimada K; Crother TR; Chen S; Brikos C; Bulut Y; Latz E; Underhill D; Arditi M
J Immunol; 2010 Jun; 184(11):6359-66. PubMed ID: 20435923
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.
Tissières P; Araud T; Ochoda A; Drifte G; Dunn-Siegrist I; Pugin J
J Biol Chem; 2009 Sep; 284(39):26261-72. PubMed ID: 19632992
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling.
Ohta S; Bahrun U; Tanaka M; Kimoto M
Biochem Biophys Res Commun; 2004 Oct; 323(3):1103-8. PubMed ID: 15381113
[TBL] [Abstract][Full Text] [Related]
15. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
[TBL] [Abstract][Full Text] [Related]
16. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
[TBL] [Abstract][Full Text] [Related]
17. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
18. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin.
Kawasaki K; Gomi K; Kawai Y; Shiozaki M; Nishijima M
J Endotoxin Res; 2003; 9(5):301-7. PubMed ID: 14577846
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
